Test Overview
Method
Chemiluminescent immunoassay (CLIA)
Analytical Platform
Beckman
Result Included
CK Study; CK-MB Study; CK-MB Relative Index Study
Specimen
Specimen Type
SerumContainers
Collection Containers
Gold top (clot activator & gel)
Volume
Sample Volume
1 mL
Specimen Comment
Plasma (Heparin) is acceptable but has up to +12.5% bias.
Collection & Handling
Handling Information
Store and send frozen.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 4 hours | 2 days | 3 months |
Rejection Criteria
| Criteria | Specification |
|---|---|
| Hemolysis | Gross |
Performance & Interpretation
Turnaround Time
2 days
Results
Name
Units
Reference Range
Conversion
-
CK StudyU/L30-223
-
CK-MB Studyµg/L<5
-
CK-MB Relative Index Study<0.04
Referral Location
Canada
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| CKMB | CK-MB Study | 28042 | ug/L |
| CK-MB Rel. Index Study | 28044 | ||
| CK Study | 28040 | U/L |
Test Version
Last Updated
2024-09-03